: Curaleaf issues statement on reported interest in Cronos
Curaleaf Holdings Inc. CA:CURA responded late Friday to reports it was among those interested in buying Canadian cannabis company Cronos Inc. CRON. Curaleaf said the Canadian Investment Regulatory Organization had requested a comment on market speculation. “As previously disclosed, the company regularly examines transactions including partnerships, possible acquisitions, sales and mergers with third parties,” the company said in a statement. “There is no guarantee that any potential transaction will materialize.” Earlier Friday, Curaleaf said it did not comment on market speculation about reports of a transaction unless required by law. Shares of Curaleaf closed Friday up nearly 16%, while Cronos shares finished up nearly 7%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.